Application of whole exome sequencing in undiagnosed inherited polyneuropathies

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 85, Issue 11, 2014, Pages 1265-1272

  Klein, Christopher J ^a   Middha, Sumit ^a   Duan, Xiaohui ^b   Wu, Yanhong ^a   Litchy, William J ^a   Gu, Weihong ^b   Dyck, P James B ^a   Gavrilova, Ralitza H ^a   Smith, David I ^a   Kocher, Jean Pierre ^a   Dyck, Peter J ^a  

^a MAYO CLINIC   (United States)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALGORITHM; CHILD; DNA SEQUENCE; EXOME; FEMALE; GENE; GENETIC PREDISPOSITION; GENETICS; HUMAN; INFANT; MALE; MIDDLE AGED; MUTATION; PEDIGREE; POLYNEUROPATHIES; PRESCHOOL CHILD; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; ALGORITHMS; CHILD; CHILD, PRESCHOOL; EXOME; FEMALE; GENES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; MALE; MIDDLE AGED; MUTATION; PEDIGREE; POLYNEUROPATHIES; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84895417507     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2013-306740     Document Type: Article

References (35)

1. Dyck PJ, Oviatt KF, Lambert EH. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol 1981;10:222-6.
2. Saporta AS, Sottile SL, Miller LJ, et al. Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann Neurol 2011;69:22-33.
3. Latour P, Vial C. [Molecular diagnosis of axonal forms of Charcot-Marie-Tooth disease]. Rev Neurol (Paris) 2009;165:1122-6.
4. Callaghan B, McCammon R, Kerber K, et al. Tests and expenditures in the initial evaluation of peripheral neuropathy. Arch Inter Med 2012;172:127-32.
5. Guelly C, Zhu PP, Leonardis L, et al. Targeted high-throughput sequencing identifies mutations in atlastin-1 as a cause of hereditary sensory neuropathy type I. Am J Hum Genet 2011;88:99-105.
6. Montenegro G, Powell E, Huang J, et al. Exome sequencing allows for rapid gene identification in a Charcot-Marie-Tooth family. Ann Neurol 2011;69:464-70.
7. Klein CJ, Botuyan M-V, Wu Y, et al. Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat Genet 2011;43:595-600.
8. Klein CJ, Duan X, Shy ME. Inherited neuropathies: clinical overview and update. Muscle Nerve 2013;48:604-22.
9. McKenna A, Hanna M, Banks E, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010;20:1297-303.
10. Asmann YW, Middha S, Hossain A, et al. TREAT: a bioinformatics tool for variant annotations and visualizations in targeted and exome sequencing data. Bioinformatics 2012;28:277-8.
11. Bentley DR, Balasubramanian S, Swerdlow HP, et al. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 2008;456:53-9.
12. Craig DW, Pearson JV, Szelinger S, et al. Identification of genetic variants using bar-coded multiplexed sequencing. Nat Methods 2008;5:887-93.
13. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009;25:1754-60.
14. Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 2010;26:841-2.
15. Cho HJ, Sung DH, Ki CS. Identification of de novo BSCL2 Ser90Leu mutation in a Korean family with Silver syndrome and distal hereditary motor neuropathy. Muscle Nerve 2007;36:384-6.
16. James PA, Cader MZ, Muntoni F, et al. Severe childhood SMA and axonal CMT due to anticodon binding domain mutations in the GARS gene. Neurology 2006;67:1710-12.
17. Durr A, Camuzat A, Colin E, et al. Atlastin1 mutations are frequent in young-onset autosomal dominant spastic paraplegia. Arch Neurol 2004;61:1867-72.
18. Zuchner S, Mersiyanova IV, Muglia M, et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004;36:449-51.
19. Windpassinger C, Auer-Grumbach M, Irobi J, et al. Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome. Nat Genet 2004;36:271-6.
20. Street VA, Bennett CL, Goldy JD, et al. Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C. Neurology 2003;60:22-6.
21. Ming L. [SPG3A-hereditary spastin paraplegia with genetic anticipation and incomplete penetrance]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2007;24:15-18.
22. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study. Neurology 1993;43:817-24.
23. Sivakumar K, Kyriakides T, Puls I, et al. Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations. Brain 2005;128(Pt 10):2304-14.
24. Puls I, Jonnakuty C, LaMonte BH, et al. Mutant dynactin in motor neuron disease. Nat Genet 2003;33:455-6.
25. Farrer MJ, Hulihan MM, Kachergus JM, et al. DCTN1 mutations in Perry syndrome. Nat Genet 2009;41:163-5.
26. Beetz C, Schule R, Deconinck T, et al. REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31. Brain 2008;131(Pt 4):1078-86.
27. Beetz C, Pieber TR, Hertel N, et al. Exome sequencing identifies a REEP1 mutation involved in distal hereditary motor neuropathy type V. Am J Human Genet 2012;91:139-45.
28. Klein CJ, Wu Y, Kruckeberg KE, et al. SPTLC1 and RAB7 mutation analysis in dominantly inherited and idiopathic sensory neuropathies. J Neurol Neurosurg Psychiatry 2005;76:1022-4.
29. Ewing B, Hillier L, Wendl MC, et al. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res 1998;8:175-85.
30. Foo JN, Liu JJ, Tan EK. Whole-genome and whole-exome sequencing in neurological diseases. Nat Rev Neurol 2012;8:508-17.
31. Ivanova N, Claeys KG, Deconinck T, et al. Hereditary spastic paraplegia 3A associated with axonal neuropathy. Arch Neurol 2007;64:706-13.
32. Deng HX, Klein CJ, Yan J, et al. Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4. Nat Genet 2010;42:165-9.
33. Zimon M, Baets J, Auer-Grumbach M, et al. Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies. Brain 2010;11:1798-809.
34. Landoure G, Sullivan JM, Johnson JO, et al. Exome sequencing identifies a novel TRPV4 mutation in a CMT2C family. Neurology 2012;79:192-4.
35. Krumm N, Sudmant PH, Ko A, et al. Copy number variation detection and genotyping from exome sequence data. Genome Res 2012;22:1525-32.